Results 151 to 160 of about 36,966 (215)
The C-terminal 32-mer fragment of hemoglobin alpha is an amyloidogenic peptide with antimicrobial properties. [PDF]
Cell Mol Life Sci, 2023 Olari LR, Bauer R, Gil Miró M, Vogel V, Cortez Rayas L, Groß R, Gilg A, Klevesath R, Rodríguez Alfonso AA, Kaygisiz K, Rupp U, Pant P, Mieres-Pérez J, Steppe L, Schäffer R, Rauch-Wirth L, Conzelmann C, Müller JA, Zech F, Gerbl F, Bleher J, Preising N, Ständker L, Wiese S, Thal DR, Haupt C, Jonker HRA, Wagner M, Sanchez-Garcia E, Weil T, Stenger S, Fändrich M, von Einem J, Read C, Walther P, Kirchhoff F, Spellerberg B, Münch J. +37 moreeuropepmc +1 more sourceMulticenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. [PDF]
N Engl J Med, 2022 Bionic Pancreas Research Group, Russell SJ, Beck RW, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Calhoun P, Wadwa RP, Buckingham B, Zhou K, Daniels M, Raskin P, White PC, Lynch J, Pettus J, Hirsch IB, Goland R, Buse JB, Kruger D, Mauras N, Muir A, McGill JB, Cogen F, Weissberg-Benchell J, Sherwood JS, Castellanos LE, Hillard MA, Tuffaha M, Putman MS, Sands MY, Forlenza G, Slover R, Messer LH, Cobry E, Shah VN, Polsky S, Lal R, Ekhlaspour L, Hughes MS, Basina M, Hatipoglu B, Olansky L, Bhangoo A, Forghani N, Kashmiri H, Sutton F, Choudhary A, Penn J, Jafri R, Rayas M, Escaname E, Kerr C, Favela-Prezas R, Boeder S, Trikudanathan S, Williams KM, Leibel N, Kirkman MS, Bergamo K, Klein KR, Dostou JM, Machineni S, Young LA, Diner JC, Bhan A, Jones JK, Benson M, Bird K, Englert K, Permuy J, Cossen K, Felner E, Salam M, Silverstein JM, Adamson S, Cedeno A, Meighan S, Dauber A. +79 moreeuropepmc +1 more sourceThe hidden risk factors behind of suicidal behavior in medical students: a cross-sectional cohort study in Mexico. [PDF]
Front PsychiatryMartinez-Fierro ML, Reyes-Hurtado JR, Ayala-Haro AE, Avila-Carrasco L, Ramirez-Hernandez LA, Lozano-Razo G, Zavala-Rayas J, Vazquez-Reyes S, Mauricio-Gonzalez A, Velasco-Elizondo P, Juarez-Alcala V, Flores-Vazquez R, Delgado-Enciso I, Rodriguez-Sanchez IP, Garza-Veloz I. +14 moreeuropepmc +1 more sourceEvaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice. [PDF]
Cancers (Basel)Wanniarachchi HI, Schuetze R, Deng Y, Hamal KB, Pavlich CI, Tankoano PEO, Tamminga C, Hammers H, Kapur P, Bueno LMA, Rayas R, Wang T, Liu L, Trawick ML, Pinney KG, Mason RP. +15 moreeuropepmc +1 more sourceInsulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. [PDF]
DiabetologiaNadeau KJ, Arslanian SA, Bacha F, Caprio S, Chao LC, Farrell R, Hughan KS, Rayas M, Tung M, Cross K, El Ghormli L, TODAY Study Group. +11 moreeuropepmc +1 more source